In terms of the prognosis of patients with myositis-associated ILD, recent studies have focused primarily on exploring risk factors for patients with anti-MDA5-positive DM [9, 34, 35], with limited attention to the prognosis of patients with ADM-ILD. This evidence concerns the gene IFIH1 and interstitial lung disease.